Comprehensive Genomic Profiling Helps Accelerate Second-Line Therapy and Potentially Avoid Ineffective Adjuvant Therapy in Resected Early-Stage Lung Adenocarcinoma
Comprehensive genomic testing is beneficial for patients at all stages of lung adenocarcinoma, according to a recent study.